Phyllis Gardner - Net Worth and Insider Trading
Phyllis Gardner Net Worth
The estimated net worth of Phyllis Gardner is at least $12,390 dollars as of 2024-11-13. Phyllis Gardner is the Director of Revance Therapeutics Inc and owns about 3,000 shares of Revance Therapeutics Inc (RVNC) stock worth over $12,390. Details can be seen in Phyllis Gardner's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Phyllis Gardner has not made any transactions after 2018-03-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Phyllis Gardner
Phyllis Gardner Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Phyllis Gardner owns 4 companies in total, including Revance Therapeutics Inc (RVNC) , CohBar Inc (CWBR) , and Corium International Inc (CORI) among others .
Click here to see the complete history of Phyllis Gardner’s form 4 insider trades.
Insider Ownership Summary of Phyllis Gardner
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RVNC | Revance Therapeutics Inc | 2018-03-16 | director |
| CWBR | CohBar Inc | 2019-02-11 | director |
| CORI | Corium International Inc | 2018-11-27 | director |
 | | 2021-03-04 | director |
Phyllis Gardner Latest Holdings Summary
Phyllis Gardner currently owns a total of 1 stock. Phyllis Gardner owns 3,000 shares of Revance Therapeutics Inc (RVNC) as of March 16, 2018, with a value of $12,390.
Latest Holdings of Phyllis Gardner
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RVNC | Revance Therapeutics Inc | 2018-03-16 | 3,000 | 4.13 | 12,390 |
Holding Weightings of Phyllis Gardner
Phyllis Gardner Form 4 Trading Tracker
According to the SEC Form 4 filings, Phyllis Gardner has made a total of 0 transactions in Revance Therapeutics Inc (RVNC) over the past 5 years. The most-recent trade in Revance Therapeutics Inc is the sale of 5,333 shares on March 16, 2018, which brought Phyllis Gardner around $168,043.
Insider Trading History of Phyllis Gardner
- 1
Phyllis Gardner Trading Performance
Phyllis Gardner Ownership Network
Ownership Network List of Phyllis Gardner
Ownership Network Relation of Phyllis Gardner
Phyllis Gardner Owned Company Details
What does Revance Therapeutics Inc do?
Who are the key executives at Revance Therapeutics Inc?
Phyllis Gardner is the director of Revance Therapeutics Inc. Other key executives at Revance Therapeutics Inc include Chief Financial Officer Tobin Schilke , President Dustin S Sjuts , and SVP & GC & Secretary Dwight Moxie .
Revance Therapeutics Inc (RVNC) Insider Trades Summary
Over the past 18 months, Phyllis Gardner made no insider transaction in Revance Therapeutics Inc (RVNC). Other recent insider transactions involving Revance Therapeutics Inc (RVNC) include a net sale of 124,284 shares made by Mark J Foley , a net sale of 35,664 shares made by Tobin Schilke , and a net sale of 64,379 shares made by Dwight Moxie .
In summary, during the past 3 months, insiders sold 0 shares of Revance Therapeutics Inc (RVNC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 294,445 shares of Revance Therapeutics Inc (RVNC) were sold and 30,000 shares were bought by its insiders, resulting in a net sale of 264,445 shares.
Revance Therapeutics Inc (RVNC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Revance Therapeutics Inc Insider Transactions
Phyllis Gardner Mailing Address
Above is the net worth, insider trading, and ownership report for Phyllis Gardner. You might contact Phyllis Gardner via mailing address: 618 Mirada Avenue, Stanford Ca 94305.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
